This summary highlights major health news, including EU's endorsement of Novo Nordisk's Wegovy for heart conditions in ...
Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
TAG24 NEWS on MSN16h
FDA approves a first-of-a-kind flu vaccine in the form of a nasal spray!In a first, the Food and Drug Administration on Friday approved AstraZeneca's FluMist, a nasal spray flu vaccine that anyone ...
In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first “self-administered” influenza vaccine — though a delay in the change ...
AstraZeneca's FluMist influenza vaccine, which can be self-administered. Experts hope an option for at-home flu vaccination ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before ...
The most recent trading session ended with Astrazeneca (AZN) standing at $78.38, reflecting a -0.66% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback